Fintel reports that on December 17, 2025, RBC Capital maintained coverage of Becton, Dickinson and (NYSE:BDX) with a Sector Perform recommendation. Analyst Price Forecast Suggests 5.82% Upside As of ...
FRANKLIN LAKES — The borough has received notice from The Hekemian Group that it has reached an agreement with Becton Dickinson to acquire 60 acres of the company's 140-acre headquarters campus off ...
We initiated a long position in Becton, Dickinson and Company common stock during the quarter. Most of its revenue comes from selling low-priced yet essential consumable medical supplies and devices ...
Becton, Dickinson and Company (NYSE:BDX) is included among the 13 Incredibly Cheap Dividend Stocks to Invest in. Becton, Dickinson and Company (NYSE:BDX), which positions itself as a medical ...
A behind-the-scenes blog about research methods at Pew Research Center. For our latest findings, visit pewresearch.org. Every survey finding published by Pew Research ...
Kovitz Investment Group Partners, LLC, an investment management company, released its “Kovitz Core Equity Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In ...
Shares of Becton Dickinson & Co. BDX slipped 1.05% to $176.37 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.60% to 6,238.01 ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Shares of Becton Dickinson and Co. dropped in early Monday trading after the medical-products company announced a deal to merge its biosciences and diagnostic business with Waters Corp. The deal, ...
Becton Dickinson’s BDX-0.15%decrease; red down pointing triangle plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and diagnostic solutions business ...